Detalles de la búsqueda
1.
Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis.
BMC Cancer
; 23(1): 446, 2023 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37193978
2.
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.
Hematol Oncol
; 41(3): 463-473, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36420747
3.
Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities.
J Biomed Sci
; 30(1): 3, 2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627707
4.
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
Am J Hematol
; 98(3): 398-407, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36588411
5.
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
Am J Hematol
; 98(5): 760-769, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36861732
6.
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience.
Ann Hematol
; 101(2): 349-358, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34766217
7.
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax.
Ann Hematol
; 99(3): 501-511, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31965269
8.
Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies.
BMC Infect Dis
; 19(1): 635, 2019 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31315582
9.
Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan.
J Formos Med Assoc
; 118(10): 1466-1470, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31337522
10.
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.
Eur J Haematol
; 101(1): 86-94, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29624746
11.
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.
BMC Gastroenterol
; 18(1): 6, 2018 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29310589
12.
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment.
Int J Hematol
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38671183
13.
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations.
Blood Cancer J
; 14(1): 15, 2024 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253683
14.
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.
Blood Cancer J
; 14(1): 57, 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594285
15.
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA.
Haematologica
; 103(11): e510-e513, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29773598
16.
A case of acute myelomonocytic leukemia morphologically mimicking lymphoblastic leukemia.
Clin Case Rep
; 11(4): e7146, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37006841
17.
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML.
Blood Cancer J
; 13(1): 4, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599822
18.
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.
Blood Cancer J
; 13(1): 120, 2023 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558665
19.
Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study.
Cancer Rep (Hoboken)
; 5(3): e1488, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34196132
20.
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission.
Bone Marrow Transplant
; 57(1): 95-105, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34671120